SEC 13F Intelligence

Venrock Adviser, LLC / RYTM

Venrock Adviser, LLC’s Rhythm Pharmaceuticals Inc Position

Does Venrock Adviser, LLC own Rhythm Pharmaceuticals Inc (RYTM)? Not currently — the last reported position was 496.0K shares worth $23M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$23M
Q4 2023
Shares
496.0K
% of Portfolio
+1.56%
Quarters Held
3
position exited

Position History RYTM

Reported value by quarter
Q2 ’23: $18MQ2 ’23Q3 ’23: $25MQ3 ’23Q4 ’23: $23MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023496.0K$23M+1.56%
Q3 20231.09M$25M+2.63%
Q2 20231.09M$18M+2.87%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of RYTM.